Pfizer Zithromax Settlement Signals More State Drug Advertising Oversight
Executive Summary
Pfizer's $6 mil. Zithromax settlement with 19 state attorneys general over promotions for the antibiotic signals an increase in state oversight of drug promotional practices
You may also be interested in...
Antibiotic Resistance, Drug Prescribing Trends To Be Tracked By Database
An FDA-contracted database will track emerging antibiotic resistance patterns and physician prescribing patterns
Antimicrobial Advertising Guidance Should Target Resistance - FDA Group
An FDA guidance on direct-to-consumer advertising of antimicrobials should address resistance issues, an agency-wide task force report suggests.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011